These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8866932)

  • 1. Antidepressant induced mania in obsessive compulsive disorder.
    Berk M; Koopowitz LF; Szabo CP
    Eur Neuropsychopharmacol; 1996 Mar; 6(1):9-11. PubMed ID: 8866932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 3. First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review.
    Bertolín S; Alonso P; Segalàs C; Real E; Alemany-Navarro M; Soria V; Jiménez-Murcia S; Crespo JM; Menchón JM
    J Psychiatr Res; 2021 May; 137():319-327. PubMed ID: 33744511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced mania.
    Mundo E; Ronchi P; Bellodi L
    Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
    Jenike MA; Baer L; Greist JH
    J Clin Psychopharmacol; 1990 Apr; 10(2):122-4. PubMed ID: 2140372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do antidepressant-induced manic episodes in obsessive-compulsive disorder patients represent the clinical expression of an underlying bipolarity?
    Amerio A; Odone A; Marchesi C; Ghaemi SN
    Aust N Z J Psychiatry; 2014 Oct; 48(10):957. PubMed ID: 24711576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG; Bouhassira M; Lancrenon S
    Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder.
    Steiner W
    Am J Psychiatry; 1991 Oct; 148(10):1403-4. PubMed ID: 1897626
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report.
    White K; Keck PE; Lipinski J
    Compr Psychiatry; 1986; 27(3):211-4. PubMed ID: 3458554
    [No Abstract]   [Full Text] [Related]  

  • 19. [A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine].
    Bernardo M; Vieta E; Vallejo J
    Med Clin (Barc); 1989 Oct; 93(10):395. PubMed ID: 2607791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.